Clear Cell Renal Cell Carcinoma — Trials

Clear Cell Renal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

247 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 114
Recruiting: 60
Ph III recruiting: 6
Growth YoY: −11.4%
Industry share: 30%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 44%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (39)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07671417	Imaging Study in Metastatic Clear Cell RCC.	not yet recruiting	Early Phase 1	10	RayzeBio, Inc.INDUSTRY	1	Jul 16, 2026	clinicaltrials
NCT02210117	Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery	active not recruiting	Early Phase 1	104	M.D. Anderson Cancer CenterOTHER	1	Jun 1, 2026	clinicaltrials